UBS Starts Cardinal Health (CAH) at Neutral

October 6, 2016 7:00 AM EDT
Get Alerts CAH Hot Sheet
Price: $74.95 -0.83%

Rating Summary:
    11 Buy, 12 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade CAH Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

UBS initiates coverage on Cardinal Health (NYSE: CAH) with a Neutral rating and a price target of $82.00.

Analyst Michael Cherny commented, "We are initiating coverage of Cardinal Health with a Neutral rating and an $82.00 price target. CAH is in the midst of a broad-based business evolution, expanding its value proposition to hospitals by moving upstream in medical supplies / devices manufacturing while also strengthening its specialty footprint. Meanwhile, the core pharma distribution business continues to benefit from shares gains as well as acquisitions by CVS, its largest customer. However, despite these positive trends, the uncertainty surrounding drug pricing is likely to cap multiples at below historical levels, leaving upside limited near-term."

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $75.88 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities


Add Your Comment